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Abstract Airway remodeling is generally quite broadly de-
fined as any change in composition, distribution, thickness,
mass or volume and/or number of structural components ob-
served in the airway wall of patients relative to healthy indi-
viduals. However, two types of airway remodeling should be
distinguished more clearly: (1) physiological airway remodel-
ing, which encompasses structural changes that occur regular-
ly during normal lung development and growth leading to a
normal mature airway wall or as an acute and transient re-
sponse to injury and/or inflammation, which ultimately results
in restoration of a normal airway structures; and (2) patholog-
ical airway remodeling, which comprises those structural al-
terations that occur as a result of either disturbed lung devel-
opment or as a response to chronic injury and/or inflammation
leading to persistently altered airway wall structures and func-
tion. This review will address a few major aspects: (1) what
are reliable quantitative approaches to assess airway remodel-
ing? (2) Are there any indications supporting the notion that
airway remodeling can occur as a primary event, i.e., before
any inflammatory process was initiated? (3) What is known
about airway remodeling being a secondary event to inflam-
mation? And (4), what can we learn from the different animal
models ranging from invertebrate to primate models in the
study of airway remodeling? Future studies are required ad-
dressing particularly pheno-/endotype-specific aspects of air-
way remodeling using both endotype-specific animal models
and Bendotyped^ human asthmatics. Hopefully, novel in vivo
imaging techniques will be further advanced to allow moni-
toring development, growth and inflammation of the airways
already at a very early stage in life.
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Introduction
With more than 241 million prevalent cases in 2013 (Global
Burden of Disease Study 2013 Collaborators 2015), asthma is
one of the most common lung diseases worldwide and it is
expected that the number of people suffering from this chronic
lung disease increases to about 300 million in 2025 (Croisant
2014). In 2013, asthma ranked 15th among all diseases world-
wide with regard to years lived with the disability (YLD) over
all age groups (Global Burden of Disease Study 2013
Collaborators 2015). Notably, asthma is most prevalent in
children with highest YLDs observed in the age group 5–14
years (ranked 6th worldwide, even 2nd in the group of devel-
oped countries) (see http://vizhub.healthdata.org/gbd-
compare/). On the basis of disability-adjusted life years, the
impact of asthma is estimated being similar to other major
chronic diseases such as diabetes or Alzheimer disease
(Croisant 2014). Even though asthma is generally not seen
as a major cause of death, the Global Burden of Disease
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Study 2013 reported a global age-standardized death rate of
8.0 per 100,000 in 2013, which is equivalent to breast cancer
(7.4) or pedestrian road injuries (8.0). Hence, asthma remains
among the top 50 causes of global years of life lost (GBD
2013 Mortality and Causes of Death Collaborators 2015).
A brief search for the available literature in PubMed using
the strategy Bairway AND asthma AND (remodeling OR
remodelling)^ revealed that, in 1993, the first two papers fall-
ing into this category were published and that numbers slowly
increased to 203 in 2007. Since then, the number of papers per
year are on a relatively constant level of between 200 and 240,
which represent only approx. 15% of all publications on
Basthma AND airway .^ Notably, among these publications,
about 50–60 per year are review papers, i.e., 20–40% of all
publications. To avoid carrying coals to Newcastle, in the
present review we will not try to review everything already
well reviewed by others (Elias 2000; Holgate et al. 2000;
Saetta and Turato 2001; Jeffery 2004; Hogg 2004; Bai and
Knight 2005; Boulet and Sterk 2007; Al-Muhsen et al. 2011;
Martinez and Vercelli 2013; Saglani and Lloyd 2015). Instead,
we will focus on some aspects related to a methodologically
sound quantification as a prerequisite for the reliable assess-
ment of airway remodeling and on what we can learn from
invertebrate to primate animal models to better understand the
mechanisms underlying physiological versus pathological
remodeling.
Today’s perception of bronchial asthma:
the phenotype/endotype concept
The perception of bronchial asthma has fundamentally
changed during the last decade. Consequently, the Global
Initiative for Asthma (GINA) suggested a new definition of
asthma: BAsthma is a heterogeneous disease, usually charac-
terized by chronic airway inflammation. It is defined by the
history of respiratory symptoms such as wheeze, shortness of
breath, chest tightness and cough that vary over time and in
intensity, together with variable expiratory airflow limitation^
(Reddel et al. 2015). The definition takes into account that
during the last decade asthma turned out to be quite heteroge-
neous encompassing patients with different phenotypes (i.e.,
the entity of observable characteristics), which, however, ex-
hibit overlap to variable degrees. Adult asthma was suggested
to be not a single disease but a syndrome with one common
feature being a variable expiratory airflow limitation (Lötvall
et al. 2011; Wenzel 2006). The concept of asthma as a syn-
drome is also expected to be very helpful in pediatric asthma
(Spycher et al. 2010; Lødrup Carlsen and Carlsen 2012).
However, the characteristics used for the definition of the var-
ious phenotypes are not necessarily directly related to the un-
derlying pathogenetic process(es). Aiming at the development
of personalized therapies, i.e., therapeutic approaches targeting
key elements of the causative pathomechanism(s), the concept
of asthma endotypes was proposed with each endotype being
the result of a specific molecular pathomechanism that is dis-
tinctly different from the other endotypes (Lötvall et al. 2011;
Wenzel 2012; Agache et al. 2012). Until today, probably the
(one and only) most clearly defined asthma endotype is the
one termed the Th2 (T helper type 2)-high endotype, which is
characterized by a T helper lymphocyte type 2-driven inflam-
mation (Fahy 2015). Anti-inflammatory therapies targeting
Th2 cytokines such as interleukin (IL)-4, IL-5 and IL-13 have
consistently exhibited beneficial effects in adult patients diag-
nosed as Th2-high asthmatics on the basis of some emerging
biomarkers related to the IL-13 response, such as periostin or
FeNO (Bhakta and Woodruff 2011; Ingram and Kraft 2012;
Fahy 2015; Fajt and Wenzel 2016). Efforts are being under-
taken to reveal additional novel biomarkers that may help in
identifying and distinguishing further endotypes (Zissler et al.
2016).
The current phenotype/endotype concept of asthma has a
strong focus on clinical and inflammatory characteristics and
omitted aspects of airway remodeling, one important feature
of asthma, as was recently emphasized (Saglani and Lloyd
2015). Today, it is unclear whether the differences in airway
remodeling parameter values observed between individual pa-
tients define specific remodeling phenotypes and how these
may relate to clinical or inflammatory phenotypes or are even
linked to a specific endotype.
Defining airway remodeling in asthma: physiological
versus pathological processes
Most review papers define airway remodeling quite broadly as
any change in composition, distribution, thickness, mass or
volume and/or number of structural components observed
in the airway wall of patients relative to the airway wall of
normal healthy individuals (Bergeron et al. 2009; Bai 2010;
Hirota and Martin 2013). Changes have been described for
various tissues in asthma patients, such as airway epithelium
(e.g., epithelial shedding, goblet cell hyperplasia, basal mem-
brane thickening), peribronchial interstitial tissue (e.g.,
subepithelial fibrosis), airway smooth muscle cells (e.g., hy-
perplasia and/or hypertrophy), nerve tissue (e.g., increased
neurite sprouting) and bronchial vasculature (e.g., barrier dys-
function, angiogenesis) (Undem et al. 1999; Beckett et al.
2003; Jeffery 2004; Al-Muhsen et al. 2011). The observation
of an inflammatory infiltrate characterized by eosinophilic
granulocytes and CD4+ Th cells in the airways of (probably
Th2-high) asthmatics (Saetta and Turato 2001), sometimes
being the result of a longstanding inflammatory process, was
suggested as a conditio sine qua non of the definition of air-
way remodeling in asthma (Hirota and Martin 2013).
Although airway remodeling has been reported for other
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chronic lung diseases such as chronic obstructive pulmonary
disease (COPD), some structural changes of the airways ap-
pear to be distinctly different when comparing asthma and
COPD as reviewed recently (Jones et al. 2016). The evidence
accumulated until now suggests that airway remodeling is
associated with a progressive loss of lung function, a view
which still has to be considered a hypothesis because therapies
targeting airway remodeling are still missing (Pascual and
Peters 2005).
In this review, we adopt the suggestions made by
Jeffery (2001, 2004) and distinguish two types of airway
remodeling, i.e., physiological remodeling on the one hand
and pathological remodeling on the other. Physiological
airway remodeling comprises those structural changes,
which occur regularly during normal lung development
and growth leading to a normal mature airway wall or
that occur as an acute and transient response to injury
and/or inflammation ultimately resulting in restoration of
a normal airway structure. Structural alterations that occur
as a result of either disturbed lung development or as a
response to chronic injury and/or inflammation leading to
persistently altered airway wall structures and function are
considered as pathological airway remodeling.
The most relevant implications of these definitions are:
& Unless quantitative analyses of airway structural charac-
teristics are used, objective evidence of structural devia-
tions from the normal healthy condition cannot be provid-
ed without doubt.
& Although airway remodeling is frequently associated with
airway inflammation, remodeling cannot be considered
being a secondary phenomenon to inflammation in every
single case.
& Airway remodeling may be a primary event in asthma
pathogenesis if it is the result of disturbed lung
development.
& Unless the kinetics of these processes can be revealed,
which is very difficult in humans, it will be very difficult
to distinguish an acute and transient response from a
chronic reaction and, thereby, unequivocally differentiate
between physiological and pathological processes. In the
absence of data on the kinetics, additional criteria/
biomarkers are badly needed and animal models can be
very helpful in that they allow for kinetic studies.
Consequently, the following major questions will be
addressed:
& what are reliable quantitative approaches to assess airway
remodeling,
& are there any indications supporting the notion that airway
remodeling can occur as a primary event, i.e., before any
inflammatory process was initiated,
& what do we know about airway remodeling being a sec-
ondary event to inflammation and
& what can we learn from animal models in the study of
airway remodeling for distinguishing physiological and
pathological airway remodeling and the underlying, po-
tentially differing pathomechanisms?
Quantitative approaches to assess airway remodeling
The initial approach to assess airway remodeling, both in
humans and in animal models, has been the histologic
analysis of two-dimensional sections by means of light,
fluorescence or electron microscopy. Recent technologi-
cal advances allowed the implementation of high-
resolution imaging into radiologic analyses of airway
morphology (Hartley et al. 2016). These approaches,
however, are beyond the expertise of the authors and
therefore this review will focus on microscopy-based ap-
proaches only.
In 2010, a joint task force of the American Thoracic
Society (ATS) and the European Respiratory Society (ERS)
published an Official Research Policy Statement paper that
critically reviewed the state-of-the-art stereological methods
in lung morphometry and defined standards to promote com-
parability of morphometric studies in pulmonary research
(Hsia et al. 2010). This landmark paper is suggested as the
starting point for everyone designing new studies of airway
remodeling and is a benchmark paper when evaluating pub-
lished data. As was emphasized by this task force, the quanti-
fication of structures is based upon the three-dimensional (3D)
physical attributes of its components. When two-dimensional
(2D) sections are used for quantitative analysis, only incom-
plete information about the 3D structure are obtained, which
bears a high risk of misinterpretations and false conclusions
(Hsia et al. 2010). This risk is particularly prominent for the
airway tree, which is highly anisotropic and exhibits marked
qualitative and quantitative changes in airway wall structure
from proximal to distal airway generations (Crystal et al.
1997; Mauroy et al. 2004). Consequently, quantitative ap-
proaches to assess remodeling of airways have to take into
account that both the orientation of a 2D section relative to
the airway’s longitudinal axis and the location along the air-
way tract (i.e., airway hierarchy) have marked effects on the
quantitative parameters analyzed (Hsia et al. 2010). Therefore,
obtaining a collection of an unbiased set of representative
tissue samples requires a few but important additional steps
during sampling, as described previously for whole lungs ob-
tained from animal models (Hyde et al. 2007; Mühlfeld and
Ochs 2013) but also for studying human biopsies (Ferrando
et al. 2003; Woodruff and Innes 2006; Bratu et al. 2014).
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A few examples could illustrate that using quantitative
stereological approaches may challenge some generally ac-
cepted views.
Epithelial cell shedding Today, it is widely accepted that the
airway epithelium, which is in almost1 direct contact to the
inhaled air, is far more than just a passive physical barrier to
what is inhaled during breathing (Tam et al. 2011). The epi-
thelium exerts various functions that help maintain a
healthy lung such as particle clearance, fluid balance, innate
immune responses. Direct injury to the airway epithelium in-
duced by various triggers has long been widely accepted as a
very early, may be the initial, step in asthma pathogenesis (Al-
Muhsen et al. 2011; Hirota and Martin 2013; Holt et al. 2014).
This notion is in part based on the qualitative observation of a
denuded epithelial basal lamina in biopsies of asthmatics,
which was interpreted as the result of epithelial cell shedding
and a histological reflection of the loss of airway epithelial
function (for references of original studies, see, e.g.,
Bergeron et al. 2009; Fajt and Wenzel 2016). A computer-
based quantitative study of bronchial biopsies obtained from
14 mild and moderate human asthmatics, however, revealed
that there were no differences in the degree of epithelial des-
quamation in comparison to biopsies from 12 healthy subjects
(Ordoñez et al. 2000). Using glycol methacrylate as embed-
ding medium for the biopsies, a section thickness of 2 μm
could be achieved, which allowed an excellent presentation
of all structures in the microscopic images. The authors sug-
gested that epithelial desquamation in endobronchial biopsies
in asthmatics is an artifact of tissue sampling and not a true
pathologic feature of asthma. Although this was controversial-
ly discussed (Holgate et al. 2001), our own data demonstrate
that the degree of epithelial desquamation in human
endobronchial biopsies increases with decreasing biopsy size
(Fig. 1). The smaller the biopsy, the more mechanical forces
may affect the tissues during collection and embedding, which
supports the notion that epithelial desquamation is highly
prone to artefactual damage. Therefore, epithelial shedding
is a questionable phenotypic characteristic of asthma.
Without any doubt, however, it is very well supported that
dysregulated airway epithelial cell functions are a central ele-
ment in the pathogenesis of asthma (Holgate 2007, 2011a, b;
Fahy and Locksley 2011).
Epithelial basement membrane thickening The basement
membrane or basement membrane zone of the airways is an
extracellular structure specialized for the attachment of the
epithelium to the underlying extracellular matrix (Evans
et al. 2010). In the electron microscope, three layers can be
distinguished: the lamina lucida, the lamina densa and the
lamina reticularis, which have been shown to also differ in
their chemical composition. The lamina reticularis, the basal
portion of the basement membrane, can also be seen with the
light microscope and is also referred to as reticular basement
membrane (RBM) or subepithelial basement membrane.
RBM thickening was suggested to be pathognomonic of asth-
ma (Jeffery 2004). However, it has been reported to also occur
in children with cystic fibrosis (Hilliard et al. 2007).
Moreover, RBM thickening was also observed in adult
COPD patients with RBM thickness being not significantly
different from adult subjects with asthma (Liesker et al. 2009).
When analyzing RBM thickening in the airways, again one
has to take into account that there is marked variation along
the airway tree, with the RBM becoming thinner as it extends
from the trachea into the small airways (Evans et al. 2010). In
addition, RBM thickness as represented in microscopic sec-
tions strongly depends on how much the sectioning angle
deviates from the ideal situation of a section normal to the
RBM surface. Therefore, exclusion of obliquely to tangential-
ly cut tissue is a step regularly implemented into the measure-
ment of RBM thickness, although using largely subjective
criteria. Implementation of design-based stereological proto-
cols is rare, although this is the only way to guarantee random
tissue orientation (i.e., isotropic, uniformly random orienta-
tion) ensuring that tangential cuts occur with a known distri-
bution and can be handled systematically (Ferrando et al.
2003; Hsia et al. 2010). Ferrando et al. (2003) made compar-
isons using two classical procedures in parallel. Although
RBM was significantly thicker in asthmatics than in healthy
subjects, the measurements made by using design-based ste-
reology were approximately 30% smaller than measurements
made with the two classical procedures. Notably, the mean
coefficient of error for repeat measurements (i.e., the repro-
ducibility of the measurements) was 0.06 for the stereological
1 Epithelial secretory products such as mucus and/or surfactant are, however,
components that separate the air from the epithelial tissue layer.
Fig. 1 Fraction of epithelial basal membrane (BM) of human
endobronchial biopsies exhibiting complete denudation is inversely
correlated with biopsy volume (=size), which was estimated according
to the Cavalieri Principle. Figure by courtesy of Dr. V.A. Bratu, modified
from Bratu (2008); Fig. 3.4c
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approach, which is by far preferable compared with the 0.19–
0.30 in the other approaches (Ferrando et al. 2003).
Implementation of such an unbiased procedure as an objective
correction for tangential cuts could be an important step for
standardization of protocols and thus would help ensure better
comparisons of measurement data across studies and labora-
tories. Accepting that reliable methods for the quantitative
assessment of RBM thickening are crucial for obtaining sound
data, reports on therapies successfully reducing RBM thick-
ness in asthma patients, reviewed recently by Durrani et al.
(2011), should be critically re-evaluated.
Smooth muscle hyperplasia and hypertrophy The potential
role(s) of airway smooth muscle cells in the pathogenesis of
asthma symptoms, in particular with regard to airway
hyperresponsiveness, has been comprehensively reviewed
by others (An et al. 2007; Gosens and Grainge 2015). It is
widely accepted that the total amount of smooth muscle is
increased in asthma (Jeffery 2004; Fixman et al. 2007;
Durrani et al. 2011). The increase seems to involve both small
and large airways (James et al. 2012) and may be related to the
clinical severity and duration of asthma (Bai et al. 2000). In
principle, the increase in muscle mass can be achieved by an
increase in cell number (hyperplasia), by increase in cell vol-
ume (hypertrophy), or a combination of both and by addition-
al immigration of myofibroblasts (Bara et al. 2010). Distinctly
different molecular mechanisms may be considered leading to
hyperplasia or hypertrophy and both may be associated with
distinct functional consequences. Conclusive demonstration
of hyperplasia, i.e., increase in cell number, is only feasible
if an unbiased design-based stereology approach such as the
physical or optical disector is applied (Sterio 1984; Hsia et al.
2010; Gruber et al. 2012). Using an assumption-based quan-
titative approach and the mean cell diameter across the nucle-
us as surrogate for cell size, hypertrophy was reported to al-
ready be present in mild-to-moderate asthmatics and being
even more pronounced in severe asthmatics (Benayoun et al.
2003). However, using design-based stereology, a biopsy
study in adult patients with mild-to-moderate asthma demon-
strated hyperplasia of smooth muscle cells, i.e., an increase in
cell number per volume of tissue, whereas no significant in-
crease in cell size, i.e., mean cell volume in μm3, was seen
(Woodruff et al. 2004). Notably,Woodruff et al. (2004) did not
find any differences in gene expression of smoothmuscle cells
isolated by laser-capture microdissection from bronchial biop-
sies of asthmatics and healthy controls with regard to the
cellular phenotype. Regamey et al. (2008) demonstrated by
design-based stereology that both hyperplasia and hypertro-
phy occur in children with mild-to-severe asthma but that
hyperplasia was the most prominent contributor to the in-
crease in smooth muscle mass. In this study, smooth muscle
cell hyperplasia revealed to be not limited to children with
asthma but to also be present in cystic fibrosis and non-
cystic fibrosis bronchiectasis. Differentiation of hyperplasia
versus hypertrophy is important when considering airway
smooth muscle as a potential therapeutic target. Exciting
new data suggest that bronchoconstriction as a result of airway
smoothmuscle contraction appears sufficient to induce airway
remodeling via processes triggered by mechanical forces and
independent of the inflammatory response (for review see
Grainge et al. 2011; Gosens and Grainge 2015). These studies
indicate that airway smooth muscle cells may not simply be
secondary effector cells responding to an already ongoing
pathogenic process but in contrast may also be at the forefront
of disease initiation.
Airway remodeling as a secondary event
to inflammation
In fact, airway remodeling in allergic bronchial asthma is
discussed to be the result of a chronic inflammatory response
entailing on the one hand permanent airway tissue destruction
and on the other hand chronic tissue repair. Thus, chronic
airway inflammation can be described as the major force driv-
ing the processes leading to most aspects of airway remodel-
ing. This Binflammation theory^ is mainly supported by the
finding that steroid treatment in asthmatic patients does not
only reduce airway inflammation but also has beneficial ef-
fects on airway remodeling (Trigg et al. 1994; Olivieri et al.
1997; Laitinen et al. 1997; Hoshino et al. 1998, 1999, 2001;
Sont et al. 1999; Ward et al. 2002; Chetta et al. 2003).
Infiltrating cells like T helper (Th) cells, eosinophils, neutro-
phils and mast cells interact with resident cells of the airways
such as fibroblasts, smooth muscle cells, neuronal cells, epi-
thelial cells and endothelial cells by the release of a plethora of
cytokines, enzymes, metabolites and growth factors creating a
signaling environment that—under chronic conditions—re-
sults in airway remodeling.
T helper cells—in allergic bronchial especially Th2 cells—
orchestrate the allergic inflammatory response by releasing a
characteristic array of cytokines including IL-4, IL-5, IL-9 and
IL-13. Each of these cytokines has prominent functions in
directing the production of allergen-specific IgE, recruitment
of eosinophils or development of AHR; however, whether
they directly have an impact on airway remodeling is still a
matter of debate. As already mentioned, gene-targeted mouse
strains overexpressing the cytokines IL-4, IL-5, IL-9, IL-11, or
IL-13 spontaneously develop airway inflammation, AHR,
mucus hyperproduction and airway remodeling (Rankin
et al. 1996; Tang et al. 1996; Lee et al. 1997; Temann et al.
1998; Zhu et al. 1999). After these initial studies, further ex-
periments provided deeper insight into the contribution of
each of these Th2-type cytokines to airway remodeling. At
least the effects of IL-4, IL-5 and IL-9 are either dependent
on IL-13 or promote airway remodeling by supporting the
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infiltration and activation of further inflammatory cells like
eosinophils and mast cells (Cohn et al. 1997; Temann et al.
2002; Justice et al. 2002; Whittaker et al. 2002). IL-5 is es-
sential for terminal differentiation, maturation, migration and
survival of eosinophils in peripheral tissues but has no direct
effect on airway remodeling in mice (Walter et al. 2001). IL-9
enhances mucus production in an IL-13-dependent manner
(Steenwinckel et al. 2007) but also influences accumulation
of mast cells in asthmatic airways (Temann et al. 2002). The
only Th2-type cytokine that has been identified to have pro-
found effects on airway structural cells is IL-13: in mice, it
induces mucin expression and mucus metaplasia in both air-
way epithelial cells and submucosal glands through activation
of STAT-6 and also plays a key role in goblet cell hyper/
metaplasia in humans (Kuperman et al. 2002; Atherton et al.
2003). Furthermore, IL-13 induces the release of the
profibrotic TGF-β by epithelial cells (Richter et al. 2001;
Malavia et al. 2008).
Th17 cells are characterized by the secretion of IL-17 and
the expression of the transcription factor RORc in humans or
RORγt in mice, respectively. By releasing several proinflam-
matory cytokines, they can amplify inflammatory responses:
e.g., through release of IL-17 they are able to induce IL-8
secretion in epithelial cells, which in turn leads to neutrophil
recruitment. Though they are not the only source of IL-17
production in asthmatic patients, their percentage in PBMCs
and IL-17 levels in plasma concentrations correlate with dis-
ease severity, so that they could play a role especially in severe
or corticoid-refractory forms of asthma (Al-Ramli et al. 2009;
Takeda et al. 2009; Zhao et al. 2010; Doe et al. 2010).Whether
Th17 cells directly contribute to airway remodeling is part of
an ongoing discussion. In a mouse model of chronic experi-
mental asthma, the absence of Th17 cells resulted in dimin-
ished airway remodeling as demonstrated by reduced staining
of collagen fibers and α-smooth muscle actin, although aller-
gic airway inflammation remained unaltered (Zhao et al.
2013). Lu et al. (2015) also used a mouse model of chronic
experimental asthma and correlated progressively increasing
levels of Th17 cells and IL-17A with peribronchial
microvessel density. Neutralization of IL-17 abrogated these
signs of vascular remodeling. However, in both studies, lack
or reduction of IL-17 as produced by Th17 cells was
paralleled by a reduction of inflammatory cell infiltration,
neutrophils in the study of Zhao et al. (2013) or eosinophils
in the study of Lu et al. (2015), so that it is still not clear
whether they indeed have a direct effect on airway remodeling
or whether they contribute to this by enhancing the local in-
flammatory response.
Therefore, most of the effects of T helper cells on airway
remodeling appeared to be indirect and to depend on their
proinflammatory effect promoting the infiltration, especially
of eosinophils and mast cells. Under the control of IL-3, IL-5,
GM-CSF and eotaxins, eosinophils are recruited to the lung
and represent a typical characteristic hallmark of allergic air-
way inflammation in asthma (Robinson et al. 1999; Sehmi
et al. 2003). Their genuine function in the immune system
has been described as major effector cells in defense against
invading parasites. Therefore, eosinophils are capable of pro-
ducing and releasing a bunch of tissue-damaging cationic pro-
teins, enzymes and reactive oxygen species as well as of cy-
tokines, chemokines, cysteinyl leukotrienes and eicosanoids
(Kariyawasam and Robinson 2006). By releasing these prod-
ucts, eosinophils provoke airway remodeling by two different
ways, on the one hand these cells appear to be the major
source of tissue damage during allergic airway inflammation
and on the other hand they stimulate tissue repair processes.
Cationic eosinophil-derived granule proteins (EDGPs) play a
pivotal role in the first type of process since they are toxic to
cells and human tissues, as demonstrated by studies using
eosinophil- or EDGP-deficient mouse strains (Denzler et al.
2000; Lee et al. 2004b; Specht et al. 2006; Doyle et al. 2013;
Jacobsen et al. 2014). They comprise eosinophil cationic pro-
tein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil
peroxidase (EPX), galectin 10 (Gal-10) and major basic pro-
teins (MBP-1 and -2) (Acharya and Ackerman 2014). In vitro
experiments demonstrated that MBP-1, which can disrupt the
lipid bilayer membrane of the cell in vitro (Gleich et al. 1993),
EPX that produces hydrogen peroxide and EDN, a member of
the ribonuclease A superfamily, are highly cytotoxic and, thus,
could play a role in epithelial shedding as observed in allergic
bronchial asthma. Like EPX and MBP-1 ECP is a highly
cationic polypeptide with marked toxicity and neurotoxicity
(Fredens et al. 1982) and has been implicated into the devel-
opment of AHR in asthmatic patients. Besides the release of
these cytotoxic EDGPs, eosinophils contribute to aggravation
of the local inflammatory response by producing proinflam-
matorymediators such as leukotrienes.While these eosinophil
products lead to tissue destruction and promote airway inflam-
mation, eosinophils are also the main source of TGF-β, a
cytokine with anti-inflammatory as well as profibrotic proper-
ties. Hence, using an anti-IL-5 antibody, which depleted eo-
sinophils in asthmatic patients, the levels of TGF-β in the
lung, TGF-β expression in eosinophils and signs of airway
remodeling were reduced in parallel (Flood-Page et al. 2003).
Accordingly, in a mouse model of experimental allergic asth-
ma, corticosteroid treatment not only diminished eosinophil
numbers in the airways but also TGF-β expression in the lung
and airway remodeling, as assessed bymyofibroblast accumu-
lation and peribronchial fibrosis (Miller et al. 2006). These
effects can be explained by the multifaceted effects of
TGF-β on structural cells of the airway wall. Thus, it induces
peribronchial fibrosis by stimulating fibroblasts to produce
collagen and fibronectin. Furthermore, TGF-β dampens the
production of enzymes like collagenase that degrade extra-
cellular matrix proteins and increases the production of the
respective enzyme inhibitors called TIMPs (tissue inhibitor
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of metalloproteases) (Wynn 2007). Additionally, TGF-β con-
tributes to smooth muscle hyperplasia by stimulating smooth
muscle cell hyperplasia (Xie et al. 2007), by promoting the
differentiation of fibroblasts into myofibroblasts (Michalik
et al. 2009) and by enhancing the migration of smooth muscle
cells towards the epithelium to form new muscle bundles (Ito
et al. 2009).
Whether neutrophils contribute to airway remodeling like
eosinophils is not that clear, which could be because increased
neutrophil numbers are not a common feature of asthmatic
patients. These cells are found in elevated numbers in severe
and corticosteroid-refractant forms of asthma that have also
been described as Bneutrophilic^ asthma (Jatakanon et al.
1999; Foley and Hamid 2007), or in patients that suffer from
acute asthma exacerbations (Bhakta and Woodruff 2011). In
such patients, neutrophil infiltration correlated with excessive
mucus plugging, mucus gland hypertrophy, persistent airflow
limitation, shedding of the airway epithelium and thickening
of the basement membrane suggests that neutrophils are in-
deed involved in processes leading to airway remodling (Pepe
et al. 2005; Shaw et al. 2007). As the typical effector cell
population in anti-microbial Th1-type immune responses,
neutrophils are capable of releasing cytokines and growth fac-
tors as well as enzymes and metabolites targeting invading
pathogens. Among these factors are IL-9, TGF-α and
TGF-β, which have have potent effects on mucus production
and subepithelial fibrosis as described above (Foley and
Hamid 2007). The most prominent enzymes released by neu-
trophils are matrix metallo protease 9 (MMP-9) and human
neutrophil elastase. MMP-9 exhibits elastinolytic and
gelatinolytic activities and its levels in the lung have been
shown to correlate with asthma severity as well as with the
degree of subepithelial fibrosis in patients suffering from asth-
ma (Wenzel et al. 2003; Cundall et al. 2003). Like HNE, its
proteolytic activity could possibly contribute to tissue damage
and, thus, to airway remodeling. HNE is capable of degrading
collagen and elastin fibers, which impairs the integrity of the
airway wall under pathologic conditions. Furthermore, HNE
triggers secretion of TGF-β by airway smooth muscle cells
via an NF-κB-dependent pathway, which could additionally
amplify repair processes and, thus, remodeling of the airway
wall (Lee et al. 2006).
Mast cells can be described as the first responders to aller-
gen contact in local allergic responses. Cross-linking of
allergen-specific IgE that is bound to the surface of mast cells
via the high-affinity FcεRI leads to release of preformed and
de novo synthesis of numerous mediators such as histamine,
leukotrienes, prostaglandins, cytokines, growth factors,
chemokines and enzymes. Within minutes, this results in
broncho-constriction, edema and mucus secretion, which is
described as the allergic early phase response (Bradding
et al. 2006). Although mast cells are more or less resident cells
localized at the epithelial barriers of the body, they have been
found to migrate into the airway smooth muscle layer and into
submucosal glands during asthma pathogenesis. In patients
who died from fatal asthma, the numbers of degranulated mast
cells positively correlated with a greater degree of smooth
muscle shortening and larger submucosal gland area, indicat-
ing that mast cells indeed have a profound effect on structural
cells of the airway wall (Chen et al. 2004). The majority of
such mast cells produce Th2-type cytokines like IL-4 and IL-
13 (Brightling et al. 2003). Furthermore, mast cells have been
found to act on fibroblasts, myofibroblasts and smoothmuscle
cells by producing and secreting TGF-β, platelet-derived
growth factor (PDGF) and fibroblast growth factor (FGF2)
(Hirst et al. 1996; Cohen et al. 1997; Kanbe et al. 1999;
Cohen et al. 2000; Hashimoto et al. 2001). Another member
of the growth factor family is amphiregulin, which is also
released by mast cells after FcεRI cross-linking in vitro and
its expression is increased in asthmatic patients. Since, in ep-
ithelial cell lines, amphiregulin up-regulates mucine gene ex-
pression, while in asthma patients its expression correlates
with the extent of goblet cell metaplasia, mast cells could
contribute considerably to mucus hypersecretion in asthma
(Okumura et al. 2005). Furthermore, mast cell-derived
amphiregulin also induces proliferation of human primary
lung fibroblasts, so that mast cells could also play a role in
the development of subepithelial fibrosis (Wang et al. 2005).
Besides these cytokines and growth factors, mast cells are the
major source of chymase and tryptase, two enzymes that have
profound effects on structural cells of the airway wall. Thus,
tryptase has been shown not only to promote collagen synthe-
sis in fibroblasts but also to stimulate proliferation of these
cells, as well as of smooth muscle cells, epithelial cells and
endothelial cells (Cairns and Walls 1997; Compton et al.
1998; Berger et al. 2001). In contrast, chymase reduces
smooth muscle cells proliferation as induced by epidermal
growth factor (EGF) and degrades smooth muscle cell
pericellular matrix (Tchougounova et al. 2001; Lazaar et al.
2002).
Airway remodeling as a primary event
In recent years, evidence has accumulated that early life (pre-
and postnatal) exposures to various stressors increase the risk
of children to develop deficits in lung function, which in the
long run may lead to chronic respiratory diseases such as
bronchial asthma (Maritz et al. 2005; Krauss-Etschmann
et al. 2012). These early origins of lung function deficits have
been linked to adverse effects on lung development (Dezateux
and Stocks 1997; Martinez 2009; Stocks et al. 2013). Recent
studies indicate that maternal smoking during pregnancy and
even paternal smoking prior to conception may increase the
risk of children-to-be to develop wheezing or asthma later in
life (Burke et al. 2012; Perret et al. 2016; Svanes et al. 2016).
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Conceptually, such prenatal exposures may interfere either
directly with morphogenetic processes during lung develop-
ment (Harding and Maritz 2012) or indirectly via an altered
immune state of the mother (Prins et al. 2012; Arck and
Hecher 2013). As a (direct or indirect) consequence, changes
of the delicately balanced airway geometry (Mauroy et al.
2004) may ensue resulting in relevant alterations of airway
function. There is good epidemiological evidence that an in-
appropriate course of lung growth is associated with early
deficits in lung function and the risk to develop asthma in
childhood or later in l ife (Bisgaard et al . 2012;
Sonnenschein-van der Voort et al. 2014, 2015). Based on the
non-invasive high-speed interrupter technique, which allows
for the measurement of high-frequency respiratory impedance
in very young children in vivo, flow limitation in preterm
infants was suggested to be determined not only by airway
diameter and airway obstruction but also by the mechanical
properties of the airway walls (Henschen et al. 2006).
Because asthma frequently starts in childhood but unequiv-
ocal asthma diagnosis in pre-school children is very difficult,
only limited data are available that allow discussing the ques-
tion whether airway remodeling may be the primary event
initiating disease pathogenesis. Therefore, this question can-
not be answered satisfactorily today. A few quantitative stud-
ies, although not following a design-based stereological ap-
proach, addressed the initial occurrence of airway wall remod-
eling in young to very young children. Pohunek et al. (2005)
presented one of the first studies to provide evidence for air-
way remodeling very early in childhood. In a bronchial biopsy
study of 27 children aged 1.2 to 11.7 years, bronchoscoped
because of recurrent or chronic respiratory symptoms and re-
evaluated 22–80 months later, the thickness of the
subepithelial lamina reticularis was observed to be greater in
children with bronchial asthma diagnosed at follow-up, com-
pared with children who did not progress to asthma. This
suggests that remodeling may be present even before asthma
becomes symptomatic. However, remodeling was accompa-
nied by eosinophilic inflammation. The link of eosinophilic
inflammation and remodeling (recently reviewed in detail;
Saglani and Lloyd 2015), already at the initiation of the dis-
ease is indirectly supported by Saglani et al. (2007) who did
not find an increase in basement membrane nor in eosinophilic
infiltration in bronchial biopsies of children (aged 3.4–
25.9 months) with reversible airflow obstruction who, how-
ever, presented with severe, prolonged, or atypical symptoms
(Pelkonen et al. 2005). Notably, in this study, older children
(aged 6–16 years) with difficult asthma had increased base-
ment membrane thickness similar to adult asthmatics. In con-
trast, an increase in basement membrane thickness accompa-
nied by differences in extracellular matrix components was
seen in very young children (aged 4–44 months) with a high
risk of developing asthma (presence of atopic eczema or asth-
matic mother) compared to a control group (aged 3–
38 months) not exhibiting these risk factors (Berankova
et al. 2014). The increase was independent of previous wheez-
ing episodes and none of the children had a positive test for
food or inhalation allergen sensitization. Data on inflammato-
ry infiltrates were, however, not included in this study. In pre-
school children aged 7–57 months, both basement membrane
thickening and eosinophilic infiltration of the airway mucosa
where observed in confirmed wheezers versus control subjects
who had no history of wheezing or lower respiratory symp-
toms (Saglani et al. 2007). In contrast, a biopsy study in pre-
school children with severe wheezing reported a number of
characteristics of airway remodeling such as increased base-
ment membrane thickness, increase in airway smooth muscle,
vascularity and mucus gland area but failed to detect any re-
lationship with inflammatory cell counts (Lezmi et al. 2015).
In a study of 50 children at 3 years of age who underwent lung
function measurements and bronchoscopy for recurrent lower
respiratory symptoms at a mean age of 1 year, basement mem-
brane thickness and numbers of mucosal mast cells but not
eosinophils, at age 1 correlated significantly with the amount
of inhalative corticosteroids purchased at 3 years of age
(Malmström et al. 2011). However, follow-up data collected
from the same children at age 8, did not support an association
between infant basement membrane thickness and current
asthma symptoms, lung function, or airway responsiveness
(Malmström et al. 2015). The authors did not find any differ-
ence in infant airway smooth muscle area fraction or basement
membrane thickness between the patients with current or past
asthma or with no asthma, suggesting that these early life
structural changes of the airway wall is not pathognomonic.
However, one has to take into account that the quantitative
data were not obtained according to unbiased design-based
stereology.
Indirect evidence supporting the notion that airway remod-
eling may be a primary event, at least in some patients, comes
from non- or minimally-invasive functional studies that sug-
gested airway wall compliance in vivo being different in in-
fants suffering fromwheezing disorders, even when they were
asymptomatic (Frey et al. 2000). This study, however, was not
designed to distinguish whether the alterations were acquired
(e.g., by inflammatory processes) or whether they pre-existed
at the onset of wheezing. Non-invasive measurement of ex-
haled nitric oxide fraction (FeNO), a marker of pulmonary
inflammation, was assessed in a prospective birth cohort to
investigate if FeNO levels after birth in unselected newborns
were associated with asthma or atopy at school age (Usemann
et al. 2016). This prospective study demonstrated that postna-
tal FeNO measured in unselected healthy newborns was not
associated with asthma diagnosis at school age and the authors
speculated that NO metabolism might play a role in the path-
ophysiology of childhood asthma and atopy only after expo-
sure to environmental factors at pre-school age. Since indica-
tors of airway wall structure were reported in other studies to
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be already altered very early in life (see references above), one
may hypothesize that airway remodeling can indeed precede
airway wall inflammation and thus may present as a primary
event. Deciphering how early-life or even prenatal risk factor
exposures may be mechanistically linked to airway structural
and functional changes later in life will be both highly inter-
esting from a scientific perspective as well as highly important
for understanding and preventing the initiation not only of
bronchial asthma but of chronic respiratory diseases in general
(Stocks et al. 2013). Identification of relevant mechanisms
will help us in the development of effective strategies for the
early prevention of such widespread pulmonary diseases. A
lot of work awaits to be done.
Animal models in the study of airway remodeling
Mammals
Mouse
Since the 1990s, mouse models of experimental allergic asth-
ma have been utilized extensively to investigate the pathoge-
netic mechanisms underlying the formation of the disease and
have provided in-depth understanding of the role of various
cells and their products in asthma pathogenesis. Over time, a
plethora of models has been developed employing different
sensitization protocols to the model allergen ovalbumin
(OVA) or to clinically more relevant allergens such as house
dust mite (HDM), ragweed or cockroach. Once the animal has
been sensitized and develop an adaptive Th2 cell-dominated
immune response, allergic airway inflammation is directed to
the airways by short-term allergen aerosol inhalation or local
application of an allergen containing solution. Such short-term
models include allergic airway inflammation with infiltration
of eosinophils and Th2 cells, increased mucus production and
airway hyperresponsiveness (AHR) and thus display key hall-
marks of human allergic asthma. However, these models are
limited by their short-term nature and, thus, fail to reflect signs
of chronicity like chronic airway inflammation, intra-
epithelial eosinophils and airway remodeling.
These limitations have been conquered by the development
in the 2000s of mouse models of chronic experimental asthma.
More or less independently from the mode of sensitization to
the allergen, prolongation of allergen challenge was utilized to
perpetuate allergic airway inflammation and, thus, the process
of airway tissue destruction and repair, ultimately leading to
structural changes of the airway wall. We exposed OVA-
sensitized Balb/c mice (Mus musculus) to an OVA-aerosol for
20 min twice a week for 12 weeks and recorded a change of the
inflammatory pattern in the airways as well as signs of airway
remodeling (Wegmann et al. 2005). Compared to OVA-
sensitized mice exposed only twice to an OVA-aerosol, long-
term exposed animals displayed allergic airway inflammation
not only of proximal airway sections but also of the entire
airway tree. While eosinophils dominated the inflammatory
infiltrate in the short-term model, we found no eosinophils in-
filtrating the airway epithelium. In contrast, intra-epithelial eo-
sinophils were present after long-term OVA aerosol challenge
(Fig. 2), although lymphocyte numbers in the airway tissue
were much higher than eosinophil counts. A considerable part
of these lymphocytes were B cells secreting OVA-specific IgE,
IgG1 and IgA, which were nearly absent in the short-term
model (Luger et al. 2009). The survival of these cells critically
depended on the local production of neurotrophins such as
nerve growth factor (NGF) and neurotrophin 3 (NT-3), which
were largely produced in the lungs of chronically OVA-
challenged animals (Abram et al. 2009). Even after 6 weeks
without any further OVA aerosol challenge, lymphocytes were
still present in the broncho-alveolar lavage (BAL) fluid and the
airway wall, while eosinophil counts in both compartments
decreased dramatically over time, although small numbers were
still present in the airway tissue (Wegmann et al. 2005). This
change in the inflammatory pattern was further associated with
markedly increased levels of transforming growth factor β
(TGF-β) in the BAL fluid. Accordingly, we found increased
collagen fiber deposition, especially in the lamina propria and
elevated numbers of adventitial fibroblasts, indicating
subepithelial fibrosis. Staining against α-smooth muscle actin
further revealed enhanced numbers of myofibroblasts and
thickening of the smoothmuscle layer, suggesting smoothmus-
cle hyperplasia (Wegmann et al. 2007). Diminishing allergic
airway inflammation in this long-term model, either by
inhibiting eosinophil chemotaxis inhibitor or by Th2 cell
Fig. 2 Intra-epithelial eosinophilic granulocyte (arrowhead) in main
bronchus of a murine lung chronically challenged with ovalbumin ac-
cording to the protocol of Wegmann et al. (2005). Tissue was fixed with
4% paraformaldehyde, embedded into glycol methacrylate and the sec-
tion was Congo Red-stained for eosinophils. AE airway epithelium. Black
arrows indicate eosinophilic granulocytes in subepithelial interstitial
tissue
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activity, also resulted in reduced goblet cell hyperplasia, smooth
muscle cell hyperplasia and subepithelial fibrosis, suggesting
that airway remodeling is indeed dependent on an ongoing
inflammatory process in the airways (Wegmann et al. 2007;
Sel et al. 2008).
Comparable results were achieved by Kumar et al. (2000),
who avoided the common problem of tolerance induction and
lung parenchymal inflammation after chronic allergen expo-
sure in mice by inhalation of carefully controlled mass con-
centration of aerosolized OVA. Thus, OVA-sensitized Balb/c
mice were challenged with 10–20 mg/m3 aerosolized OVA
3 days a week for 8 weeks. Their phenotype of experimental
chronic asthma was characterized by chronic airway inflam-
mation, intra-epithelial eosinophils, a local Th2-biased humor-
al immune response, AHR and signs of airway remodeling,
such as subepithelial fibrosis, goblet cell hyperplasia and hy-
pertrophy of the airway epithelium (Temelkovski et al. 1998;
Foster et al. 2000, 2002; Kumar et al. 2000). A considerable
number of other models have been established inmice that use
long-term allergen provocation to induce an acute-to-chronic
inflammatory response in the airways to cause abnormal air-
way injury and to induce repair responses, which ultimately
result in airway remodeling. Beneath the above-mentioned
structural changes of the airway wall, like subepithelial fibro-
sis, smooth muscle hypertrophy and goblet cell hyperplasia,
these models also display microvascular remodeling and neo-
vascularization. Alterations of the airway epithelium also in-
volve disruption of tight junctions and increased apoptosis of
epithelial cells, which result in epithelial shedding and a com-
promised barrier function of the airway epithelium
(Hogaboam et al. 2000; Trifilieff et al. 2000; Dorscheid et al.
2003; Jain et al. 2003; Jungsuwadee et al. 2004).
It is interesting to note that the phenotype of these chronic
asthma mouse models can be induced regardless from the
allergen (OVA, HDM, Aspergillus fumigatus, etc.) or a sensi-
tization protocol that has been used to indicate that once the
animal has been sensitized structural changes of the lung are
induced by perseverative allergen provocation (Johnson et al.
2004). Since different aspects of sustained airway remodeling
persisted even after discontinuation of allergen challenge
(Leigh et al. 2002; Cho et al. 2004; Johnson et al. 2004;
McMillan and Lloyd 2004; Kumar et al. 2004; Wegmann
et al. 2005), these studies demonstrated that mice are indeed
capable to mimic allergen-induced responses of the epithelial–
mesenchymal trophic unit, leading to various signs of airway
remodeling attributed to human bronchial asthma. Therefore,
studying the chronic phases of asthma is clearly possible in
mice. Furthermore, since such studies revealed that airway
remodeling persisted after cessation of allergen challenges
well beyond the resolution of allergic inflammation, this sug-
gests that mechanisms independent of inflammation are active
in sustaining airway remodeling even when remodeling
evolved as a result of allergic airway inflammation (Foster
et al. 2000; Leigh et al. 2004; Kumar et al. 2004). The disso-
ciation of airway remodeling and allergic lung inflammation
has additionally been supported by findings in transgenicmice
as well as in studies using a therapeutic setting that reported
beneficial effects on inflammatory processes whereas features
of airway remodeling were not affected (Kerzel et al. 2009,
2011; Gregory et al. 2010; Gabehart et al. 2013).
A considerable advantage of asthma mouse models is the
availability of gene-targeted or transgenic animals and of a
plethora of specific reagents that allow the determination of
the particular contribution of individual factors (e.g., media-
tors, cells) to asthma pathogenesis. Consequently, the role of
Th2-type cytokines has been investigated in detail by subject-
ing genetically modified animals to the protocol for the induc-
tion of chronic experimental asthma. Thus, allergen-sensitized
animals lacking either IL-5 or IL-13 developed significantly
less airway remodeling compared to wild-type animals after
chronic allergen challenge (Kumar et al. 2002; Cho et al.
2004). Accordingly, animals overexpressing either IL-5 or
IL-13 spontaneously develop airway eosinophilia, AHR and
airway remodeling (Lee et al. 1997; Zhu et al. 1999).
Comparable phenotypes could be observed in mice overex-
pressing other Th2-type cytokines such as IL-9 and IL-11
(Tang et al. 1996; Temann et al. 1998). Since all these trans-
genic animals also spontaneously developed an inflammatory
response in the airways, the direct contribution of these cyto-
kines to airway remodeling is still a matter of debate.
The overexpression of classic profibrotic growth factors
such as TGF-β and vascular-endothelial growth factor
(VEGF) in the lung also produced marked airway remodeling.
Hence, conditional overexpression of TFG-β in airway epithe-
lium using a tetracycline-controlled suppressor and reverse tet-
racycline transactivator system led to profound inflammation of
the airways associated with increased collagen deposition, en-
hanced numbers of myofibroblasts and myocytes in the airway
wall and elevated apoptosis of epithelial cells. Lung-targeted
VEGF transgenic mice showed an asthma-like phenotype char-
acterized by airway inflammation and AHR together with gob-
let cell hyperplasia, edema, smooth muscle cell hyperplasia and
parenchymal and vascular remodeling (Lee et al. 2004a).
Although the use of mouse models of chronic experimental
asthma has provided deep insights into the role of various
receptors, cytokines and other factors in the pathophysiology
of allergic bronchial asthma and also in the processes ultimate-
ly leading to airway remodeling, none of these models has
been able to entirely reflect all aspects of the human disease
and they have considerable limitations. One critical point is of
course the anatomy of the murine lung that differs in a number
of aspects from the human organ. The size of the largest
intrapulmonary airways of the murine lung is approximately
at the level of small airways in humans, so that their physiol-
ogy as well as the structure of their airway wall display major
differences compared to human airways (Hyde et al. 2006).
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For example, murine airways do not display submucosal
glands, so that mucus production is entirely managed by gob-
let cells and so remodeling processes concerning such glands
cannot be investigated (Borthwick et al. 1999). Furthermore,
the murine lung lacks a normal systemic circulation to the
intra-parenchymal airways, so that processes of neo-
vascularization and vessel remodeling of the airway wall are
not fully reflected by murine models (Verloop 1949). Mice
further display a bronchial branching pattern that is different
from humans. In humans, branching is symmetrical and di-
chotomous with up to 23 generations, while in mice—as in all
non-primates—is monopodial and reaches six to eight gener-
ations (Gomes and Bates 2002). Another critical point is the
strain dependency of the phenotype (Shinagawa and Kojima
2003). In order to overcome these limitations, other species
have been used to establish models of allergic bronchial asth-
ma, including rodents like rats or guinea pigs as well as sheep,
horses, cats and monkeys.
Rat
While in mice long-term exposure to the allergen for up to 15
and more challenges is required to induce airway remodeling
(Brusasco et al. 1999;Wegmann et al. 2005), structural changes
of the airway wall have been observed surprisingly earlier in rat
models of experimental asthma. In Brown Norway rats (Rattus
norwegicus) that were systemically sensitized to OVA using
alum and Bordetella pertussis vaccine as adjuvants, an in-
creased airway smooth muscle mass in intrapulmonary airways
was already observed after three OVA aerosol challenges at day
24 (Sapienza et al. 1991). Subsequent studies using the same
protocol further showed increased proliferation and decreased
apoptosis of both airway smooth muscle and epithelial cells
(Ramos-Barbón et al. 2005), goblet cell hyperplasia
(Camateros et al. 2007) and enhanced peribronchial vessel
count indicating bronchial angiogenesis (Siddiqui et al. 2013).
Furthermore, excessive deposition of collagen type I fibers,
bigylcans (versican, biglycan, decorin and lumican) and
glycosaminogylcans (chondroitin-, dermatan-, heparin- and
keratin sulfate) indicate massive reorganization and remodeling
of the extracellular matrix (Pini et al. 2006; Venkatesan et al.
2012). Interestingly, rats that were systemically sensitized
against OVA by using alum only required at least four to six
OVA aerosol challenges to mimic these signs of airway remod-
eling (Moir et al. 2003; Leung et al. 2005; Tigani et al. 2007),
indicating that the inflammatory and remodeling processes are
not necessarily independent from the sensitization protocol.
Guinea pig
Models of allergic bronchial asthma in guinea pigs are quite
more variable. Prado and colleagues sensitized and challenged
these animals by eight OVA aerosol inhalations over a time
period of 31 days and reported allergic airway inflammation
associated with increased collagen fiber deposition (Prado
et al. 2005). Subsequent studies also found enhanced expres-
sion and content of elastic fibers and actin in the airway wall
as well as thickening of the airway epithelium and the smooth
muscle layer (Nakashima et al. 2008; Olivo et al. 2012; Pigati
et al. 2015). However, the same protocol also resulted in in-
creased matrix fiber deposition in alveolar walls, which is not
a feature a human bronchial asthma (Possa et al. 2012).
Guinea pigs have also been sensitized systemically to OVA
by using alum as an adjuvant and were subsequently chal-
lenged with OVA aerosol for up to 12 weeks, which resembles
protocols from mouse models of chronic experimental asth-
ma. Such a protocol results in profound allergic airway in-
flammation associated with goblet cell hyperplasia, mucus
gland hypertrophy, smooth muscle layer thickening and in-
creased collagen deposition (Dekkers et al. 2010; Maarsingh
et al. 2011; Lucarini et al. 2014).
Sheep
Modeling asthma in non-rodent animals is more extensive due
to issues of animal housing under laboratory conditions and to
their behavior and socialization as well as simply to their size.
However, lung and airway anatomy of sheep is much similar to
human anatomy than the lung and airway anatomy inmice, rats
and guinea pigs. Since airway remodeling proverbially alters
the micro-anatomy of the lung, this is a considerable argument.
Arguing that innervation and blood supply of the sheep lung is
nearer to the human organ situation than that of mice, Snibson
et al. (2005) used subcutaneous injection of HDM and alum to
sensitize sheep and exposed these animals overnight to HDM
aerosol for 6 months. This protocol produced allergic airway
inflammation and airway remodeling by points of goblet cell
and epithelial cell hyperplasia as well as of collagen and
smooth muscle actin content of the airways. A subsequent
study also showed increased airway vessel density, which sug-
gests vascular remodeling (Van Der Velden et al. 2013).
Cat
Particularly interesting animals for modeling human bronchial
asthma are species that spontaneously develop idiopathic
forms of asthma such as cat (Felis silvestris catus) and horse
(Equus ferus caballus). Thus, approximately 1% of the feline
population develops a disease characterized by episodes of
coughing, mucus hypersecretion and broncho-obstruction
and displays AHR as well as airway eosinophilia (Padrid
2000). Kirschvink et al. (2007a, b) sensitized cats to Ascaris
suum (AS) allergen and induced allergic airway inflammation
by AS for aerosol inhalations. The authors found increased
activity of matrix-metalloprotease (MMP) 9 and a significant
age-related increase in interstitial and total radiographic score
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as assessed by radiography suggesting ongoing airway remod-
eling processes.
Horse
Horses naturally develop a chronic obstructive respiratory
condition termed Bheaves^, characterized by AHR, recurrent
broncho-obstruction and airway inflammation with produc-
tion of Th2-type cytokines and, thus, share several similarities
with human bronchial asthma (Robinson et al. 2000). Animals
suffering from the mild-to-moderate type of heaves, which is
also termed Binflammatory airway disease (IAD)^, display
airway inflammation with neutrophils and eosinophils, while
during clinical exacerbation of heaves neutrophils become the
dominating leukocyte subpopulation in airway infiltrates
(Jean et al. 2011). Herszberg et al. (2006) exposed naturally
hay-sensitized horses to barn-dust for 30 consecutive days and
recorded increased mucus production and mucus plugging of
the airway together with signs of smooth muscle cell hyper-
plasia by points of increased α-smooth muscle actin mass and
enhanced proliferation and reduced apoptosis of smooth mus-
cle cells. A follow-up study also revealed increased collagen
content of the airway lamina propria, which positively corre-
lated with increased airway resistance (Setlakwe et al. 2014).
Rhesus monkey
In contrast to the aforementioned species, models using pri-
mates such as the rhesus monkey (Macaca mulata) offer the
advantage that monoclonal antibodies against human gene
products display considerable cross-reactivity with primate an-
tigens. Furthermore, one can argue that lung anatomy and phys-
iology of the rhesus monkey is even closer to humans then that
of quadrupeds like cats, dogs, sheep and horses. Thus, rhesus
monkeys have also been utilized to establish models of allergic
bronchial asthma and represent an important part of pre-clinical
drug testing. The group of Plopper and Hyde at UC Davis
sensitized rhesus monkeys to HDM allergen by subcutaneous
and intra-muscular injections with alum and Bordetella
pertussis as adjuvants followed by two intra-nasal applications
of HDM solutions and exposure to HDM aerosol for 11 weeks
with three exposures a week. Besides allergic airway inflam-
mation, Th2-type cytokine production and development of
AHR, this protocol also resulted in airway remodeling with
goblet cell hyperplasia, increased thickening of the basement
membrane zone, smooth muscle hypertrophy, enhanced
subepithelial vascular density and VEGF expression in the air-
ways as well as elevated density of epithelial nerves (Evans
et al. 2002; Larson et al. 2004; Tran et al. 2004; Avdalovic
et al. 2006). Moreover, this variety of structural changes were
demonstrated by using design-based stereology approaches on
clearly identified airway generations (for review, see Plopper
et al. 2007). Most notably, tracheal RBM thickening persisted
after 6-month recovery from allergen exposure (Evans et al.
2004), indicating that, according to our definition, pathological
airway remodeling is induced in this model.
Other models
Without doubt, such asthmamodels in non-rodent animals offer
the advantage of an anatomy and physiology of the lung that in
a number of aspects more closely mimics the human situation.
Further, in animals larger than rodents, various parameters to
assess the asthmatic phenotype can be recorded without
sacrificing the study object. However, the question as to which
additional insights into the mechanisms of airway remodeling
can be obtained by using these model organisms is in general
hard to answer. Especially for cats, sheep and horses, reagents
for intervention and genetically manipulated strains are only
rarely available, if at all. On the contrary, one might argue that,
instead of using more and more complex non-rodent animal
models that are expensive, time-consuming and pose high de-
mands on ethical standards, the opposite strategy, i.e., using less
complex model systems, offers some advantages.
Fruit fly
For several years, we have been using the fruit fly Drosophila
melanogaster as a non-vertebrate model system in respiratory
research in order to study innate immunity and remodeling
processes of the airway epithelium (Roeder et al. 2009). At a
first glance, it might appear all but straightforward to use an
animal that lacks active breathing for studying a pulmonary
disorder. However, even though the respiratory system of the
fruit fly is only an analogue organ to the human lung, there are
a few but important similarities between these two systems
that recommend using this model system to investigate dis-
tinct processes of respiratory biology such as epithelial remod-
eling of the airways.
In humans as well as in flies, respiration is enabled by the
airways that form a tubular network repeatedly branching
from proximal to distal, where they end blindly (Rühle
1932). In both species, epithelial cells constitute the barrier
between the organism and the environment, therebymediating
the gas exchange. While in humans a variety of different cell
types and tissues constitute the airways, the airways of the
fruit fly, termed trachea to tracheoli (Fig. 3), are formed by a
single layered and entirely immune-reactive epithelium
(Wagner et al. 2008). Its innate immune system shares a lot
of genes and molecular pathways (e.g., TNF-alpha signaling)
with the human one, which is particularly true at the level of
recognition, signaling and effectuation (Wagner et al. 2008).
This strictly pure epithelial character of the airways combined
with the lack of an adaptive immune system makes the fly a
highly interesting model system that can be used to exclusive-
ly study epithelial remodeling without having to take into
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account the impact of immune cells like T cells, B cells, mast
cells and eosinophils. The key role of the airway epithelium in
asthma pathogenesis being widely recognized (Holgate 2007;
Fahy and Locksley 2011; Lambrecht and Hammad 2014), the
unique features of Drosophila airways allow the use of this
model system primarily to investigate molecular aspects of
airway remodeling.
So far, Drosophila has been exclusively utilized to eluci-
date highly conserved signaling pathways, which have been
implicated in the pathophysiology of asthma. In this context,
the focus was on NF-ĸB signaling using ectopic activation of
the NF-ĸB signaling pathway immune deficiency (Imd),
which is the most crucial signaling pathway in mediating
epithelial immune responses in the fruit fly (Tzou et al.
2000; Wagner et al. 2008). A detailed morphological study
of these transgenic airways revealed that permanent Imd ac-
tivation results in epithelial proliferation and thickening
throughout the entire airway tree, indicating metaplastic
transformation (Wagner and co-workers, unpublished). Due
to this increased thickness, the regular structure and arrange-
ment of the epithelial cells were lost. The airway lumen ap-
peared irregular and compressed, suggesting that the animals
were not sufficiently supplied with oxygen any longer. From
points of metaplastic transformation of the airway epithelium,
this phenotype largely resembles the murine phenotype ob-
served when using ectopic activation of NF-ĸB signaling in
mice (Pantano et al. 2008).
The major advantage of the fly is that its genome can be
manipulated rapidly and easily due to the availability of a
variety of genetic tools, which are freely accessible for any-
one. Genes can be selectively switched on or off (overexpres-
sion, RNAi) in the airway epithelium by crossing a fly line
tagging the airway epithelium specifically to a line carrying
the gene of interest. Thus, this simple non-vertebrate model
exhibits a very promising potential to decipher, e.g., the func-
tional relevance of novel candidate genes suggested to be
implicated in airway epithelial remodeling.
Outlook
Evidence has increased that asthma can no longer be considered
as a single disease entity but rather as a syndrome comprising
several pheno-/endotypes, which are characterized by distinct
underlying molecular mechanisms. Whether distinct features of
airway remodeling are linked specifically to certain pheno-/
endotypes awaits future investigation. Hopefully, such studies
will implement design-based stereology, which has challenged
some traditional views deduced from assumption-based
methods, for a reliable assessment of airway remodeling. A
plethora of data was collected from both human and animal
studies supporting the notion that airway remodeling can be
the result of an inflammatory process. However, more and more
studies suggest that airway remodelingmay alternatively evolve
as a primary event initiated very early in life in the absence of
any symptoms or of any detectable inflammation. With the ad-
vancement of novel in vivo imaging techniques, monitoring of
the development and growth of the airways as well as of airway
inflammation will be feasible so that our present knowledge on
the initiation of airway remodeling can be expected to be sig-
nificantly expanded. The broad range of animal models present-
ly available from invertebrate to primate species shall be con-
sidered as an extraordinary armamentarium giving us the oppor-
tunity to select the appropriate model in the context of the spe-
cific question to be answered rather than trying to identify Bthe
one-and-only asthma model^, which in an asthma pheno-/
endotype world appears to be quite out-dated.
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Fig. 3 Transmission electron micrograph of a cross-section through a
terminal airway branch derived from the respiratory tract of Drosophila
melanogaster, 3rd instar larva. Tissue was processed as described else-
where (Fehrenbach et al. 1987). Ultrathin sections were cut on an Ultracut
E microtome, collected on formvar-coated nickel grids, stained with lead
citrate and analyzed using a Zeiss EM 900. AS airway space; BL basal
lamina; Cu cuticula; Ep epithelium; Nu nucleus and MC muscle cells.
Black arrowheads indicate a cellular junction
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